PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
Joanne I. Hsu(Harvard University), Margaret A. Goodell(Baylor College of Medicine), Christopher A. Bristow(The University of Texas MD Anderson Cancer Center), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Yuanqing Yan(University of Florida), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(University of Alabama at Birmingham), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Étienne De Braekeleer(Wellcome Sanger Institute), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Sonal Gera(The University of Texas MD Anderson Cancer Center), Ayala Tovy(Baylor College of Medicine), Mira Jeong(Baylor College of Medicine), Tajhal Dayaram(Baylor College of Medicine), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Jeffrey J. Kovacs(The University of Texas MD Anderson Cancer Center), Lawrence A. Donehower(Institute of Molecular and Cell Biology), Feng Wang(The University of Texas MD Anderson Cancer Center)
Cited by 423
Related Papers
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k